‌

US Patent 8910629 Delivery of gases to the nasal airway

Patent 8910629 was granted and assigned to OptiNose on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

OptiNose

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89106290

Patent Inventor Names

Roderick Peter Hafner0

Per Gisle Djupesland0

Date of Patent

December 16, 2014

Patent Application Number

123751150

Date Filed

July 25, 2007

Patent Citations Received

‌

US Patent 12083270 Delivery device and method

‌

US Patent 11752100 Intranasal delivery of olanzapine by precision olfactory device

‌

US Patent 11759585 Nasal drug delivery device with detachable nozzle

‌

US Patent 11878110 Intranasal device with inlet interface

‌

US Patent 11878109 Single-use nasal delivery device

‌

US Patent 11890412 Nozzles for nasal drug delivery

‌

US Patent 11690819 Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease

‌

US Patent 11690969 Delivery of gases to the nasal airway

...

Patent Primary Examiner

‌

Steven Douglas

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8910629 Delivery of gases to the nasal airway

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API